← Leaderboards
Jimmy Deon Toussaint
Theragnostic Technologies, Inc.
$1,682,982
Attributed
$3,175,464
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $771K · FY2015–19$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,175,464 · 3
By mechanism
R44$2,984,964 · 2
R43$190,500 · 1
Top collaborators
- Balaji Sitharaman4 shared
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleMonitorIodineIn VivoKidneyKidney FailureDosageHourInvestigational DrugsIn VitroDiagnosisContrast MediaKidney DiseasesDextransAnimal ModelBloodDoseFda ApprovedImageInjuryBaseInvestigational New Drug ApplicationCarbonNanostructures
Grant awards (6)
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy$748,000
R44 · FY2019 · DK · contact PI
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy$748,000
R44 · FY2018 · DK · contact PI
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy$160,500
R43 · FY2017 · DK · contact PI
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy$30,000
R43 · FY2017 · DK · contact PI
Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magnetic Resonance Imaging Contrast Agent For Diagnosis of Renal Failure$717,997
R44 · FY2016 · DK
Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magnetic Resonance Imaging Contrast Agent For Diagnosis of Renal Failure$770,967
R44 · FY2015 · DK